SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009855
Filing Date
2023-05-15
Accepted
2023-05-15 16:16:26
Documents
101
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20230331x10q.htm   iXBRL 10-Q 3071814
2 EX-31.1 fbio-20230331xex31d1.htm EX-31.1 13871
3 EX-31.2 fbio-20230331xex31d2.htm EX-31.2 14555
4 EX-32.1 fbio-20230331xex32d1.htm EX-32.1 8179
5 EX-32.2 fbio-20230331xex32d2.htm EX-32.2 8116
  Complete submission text file 0001558370-23-009855.txt   13051299

Data Files

Seq Description Document Type Size
6 EX-101.SCH fbio-20230331.xsd EX-101.SCH 98157
7 EX-101.CAL fbio-20230331_cal.xml EX-101.CAL 90029
8 EX-101.DEF fbio-20230331_def.xml EX-101.DEF 396293
9 EX-101.LAB fbio-20230331_lab.xml EX-101.LAB 699077
10 EX-101.PRE fbio-20230331_pre.xml EX-101.PRE 625393
95 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20230331x10q_htm.xml XML 2541782
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 23922622
SIC: 2834 Pharmaceutical Preparations